Grant: Project Grant
Research Institute of the McGill University Health Centre
$229,500.00
Evaluating the Trajectory of Aortic Stenosis (AS) in Quebec patients - Diagnosis, Treatments, and Outcomes
FY 2019-20
Summary
Aortic stenosis is a narrowing of the aortic valve and the only treatment is to replace the valve either by open heart surgery or by a newer technique using a catheter based approach (TAVR) which avoids opening the chest. Both techniques are effective but in the real world how it is decided which patient gets which procedure is largely unknown. The newer TAVR approach appears more expensive but provides some additional health benefits (shorter hospitalizations, better initial quality of life). In routine practice, it is unknown if all segments of the population have equal access to TAVR and if there are differences in the outcomes. This research aims to answer those question.
Department
Program
Project Grant
Location
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
420032
Name
Brophy James M
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Health Services Evaluation & Interventions Research 3
Projecttitle
Evaluating the Trajectory of Aortic Stenosis (AS) in Quebec patients - Diagnosis, Treatments, and Outcomes
Programtype2
Operating Grants
Orgnameinp2
Research Institute of the McGill University Health Centre
Cihramount2
$229,500
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Aortic Stenosis; Hierarchical Modeling; Outcomes Research; Small Area Variations
Abstract
Aortic stenosis is a narrowing of the aortic valve and the only treatment is to replace the valve either by open heart surgery or by a newer technique using a catheter based approach (TAVR) which avoids opening the chest. Both techniques are effective but in the real world how it is decided which patient gets which procedure is largely unknown. The newer TAVR approach appears more expensive but provides some additional health benefits (shorter hospitalizations, better initial quality of life). In routine practice, it is unknown if all segments of the population have equal access to TAVR and if there are differences in the outcomes. This research aims to answer those question.
Competitiondate
202003
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Brophy, James M
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $229,500~ $0~
